论文部分内容阅读
结直肠癌（ＣＲＣ）近１０年来国内外远期疗效不甚满意，５年生存率仍停留于５０％左右，而其疗效及预后又与患者的免疫状态紧密相关。为提高疗效，动态观察患者围手术期的免疫功能变化有利于对其合理施治。肿瘤标志物（ＴＭ）的检测对术后监测随访判断预后，指导术后的治疗有
The long-term curative effect of colorectal cancer (CRC) in the past 10 years is not satisfactory. The 5-year survival rate still remains at about 50%, and its efficacy and prognosis are closely related to the patient’s immune status. In order to improve the curative effect, dynamic observation of the changes in the immune function during the perioperative period is beneficial to its reasonable treatment. Detection of Tumor Markers (TM) Follow-up on postoperative monitoring to determine prognosis and guide postoperative treatment